Life Science Market Research


DxBooks Data Insights: Supply-Chain Constraints Hinder Diagnostic Testing Capabilities

  Months into the COVID-19 pandemic, U.S. testing capacity continues to lag behind its goals. The Harvard Global Institute estimated that the U.S should have at least 900,000 SARS-CoV-2 tests

AGBT 2020: DeciBio Highlights – Spatial Profiling Reloaded & MGI Unleashed

Marco Island, FL February 27, 2020 – AGBT’s 20th Anniversary didn’t disappoint, with many provocative sessions and product launches. In many ways, #AGBT20 mirrored the #AGBT19 vintage! This year, however,

The Follower’s Advantage: Cases in Life Science Research Tool Markets

The first mover’s advantage is a widespread concept in business. The idea is that a company can gain a competitive advantage by being the first to enter into an untapped

3 Machine Learning / Artificial Intelligence Trends In The Diagnostics Space For 2020 And Beyond

2019 was another strong year for machine learning and artificial intelligence within the diagnostic space, and the acceleration of progress in ML / AI is clearly going to continue within

Pain Points, Unmet Needs, and Disruption in Precision Medicine – Part 1

DeciBio’s mission is to provide market intelligence and strategic insights that drive disruption and innovation in the precision medicine and life science industry. To this end, my colleague, Colin Enderlein,

An Updated Look at TMB: What Has Changed and What to Expect

Since we last reported on the rise of tumor mutational burden (TMB) in immuno-oncology (I/O) a year ago, there have been numerous material developments of this biomarker in the I/O

AGBT 2019: Spatial Profiling Among Many Growth Applications in Genomics

Highlights from the Advances in Genome Biology Technology 2019 General Meeting It was good to be back in Marco Island for #AGBT19, and to see that genomics continues to kill

Lessons Learned from the World’s First Gene-Edited Babies

Why enforceable regulation and greater inclusion and diversity in global discourse are critical to effective management of gene editing Earlier this week, He Jiankui, a professor at China’s Southern University